ACC CardiaCast

In this episode, Gregory Piazza, MD, FACC, Elvira Grandone, MD, PhD, and Abbey R. Kruper, PsyD, ABPP walk through the clinical and emotional challenges of the link between thrombosis and fertility. They discuss how clotting disorders can influence infertility, what this means for future thrombotic and cardiovascular risk, and how to support patients who are already managing significant stress. The faculty also outlines practical guidance for counseling patients who have experienced thrombosis during pregnancy or assisted reproductive therapy and who want to continue growing their families.

In this episode, Drs. Christie Ballantyne and Anne Goldberg discuss updates on familial hypercholesterolemia (FH) diagnosis and management. Recent publications in January 2026 in the Journal of Clinical Lipidology and The Journal of Pediatrics address refined diagnostic criteria and special populations including children and pregnant women. In this podcast episode, Drs. Ballantyne and Goldberg discuss the importance of early detection, genetic testing, and treatment. To visit the course page for the Familial Hypercholesterolemia: Improving Detection to Accelerate Treatment, click here!

Jan Griffin, amyloid expert and clinician-scientist from MUSC, discusses spotting transthyretin cardiac amyloidosis. She covers cardiac clues like ECG and strain, extracardiac signs such as carpal tunnel and neuropathy, and the diagnostic algorithm including pitfalls. Treatment topics include stabilizers versus silencers, monitoring strategies, heart failure management nuances, and promising future therapies like gene editing and amyloid depletors.

ACC Chief Innovation Officer Dr. Ami Bhatt brings together Drs. Alexandre Almorad and Christopher Porterfield to discuss how advancements in pulsed field ablation (PFA) are transforming atrial fibrillation treatment. In this episode, the participants break down the latest research in PFA and explain what that means for the procedure's safety and effectiveness. This podcast is supported by Johnson & Johnson. Subscribe to CardiaCast

Prateeti Khazanie, MD, MPH, is a renowned cardiologist specializing in heart failure and cardio-renal interactions. In this discussion, she emphasizes that rising creatinine levels should not delay heart failure treatment. Khazanie explains why it’s crucial to distinguish between functional and structural kidney injuries and shares effective decongestion strategies using high-dose diuretics. She also highlights the safe use of SGLT2 inhibitors and discusses when it's necessary to involve nephrology for better patient outcomes.

Dr. Ron Blankstein, a Harvard Medical School professor and imaging expert, teams up with Dr. Lauren Baldassarre from Yale University to discuss the 2025 Advanced Training Statement on cardiovascular imaging. They dive into the need for competency-based training, how multimodality imaging is revolutionizing cardiology, and strategies to enhance education quality. They also touch on making imaging appealing for trainees, the implications of AI, and core versus focused skills for future imagers. This is a crucial conversation for the evolution of cardiovascular care.

In this episode, Alison Bailey, MD, FACC, and Melvin R. Echols, MD, FACC, discuss current pharmacological and nonpharmacological interventions to prevent and/or decrease the progression of heart failure (HF). This podcast is part of the larger Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment grant initiative, supported by Bayer AG. To visit the Managing HF Across the Spectrum page and access additional educational activities on this topic, click here. Subscribe to CardiaCast

Join Dr. Leon Ptaszek, a cardiac electrophysiologist from Harvard, and Dr. Rupal O'Quinn, Director of Cardio-Oncology, as they dive into the evolving world of wearables in cardiovascular care. They explore how consumer devices can detect low-risk symptoms, enhancing patient monitoring. The discussion includes practical tips for integrating wearable data into clinical settings, addressing challenges like data overload and access equity, and empowering patients. It's all about optimizing care and supporting better health outcomes!

In this episode, Alison Bailey, MD, FACC, and Melvin R. Echols, MD, FACC, discuss how to incorporate meaningful lifestyle modifications to prevent and/or decrease the prevention of heart failure (HF). This podcast is part of the larger Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment grant initiative, supported by Bayer AG. To visit the Managing HF Across the Spectrum page and access additional educational activities on this topic, click here. Subscribe to CardiaCast

This episode is part of ACC's ongoing initiative to advance heart failure (HF) care through team-based collaboration and patient-centered decision-making. Drs. Marty Tam, Lindsey Aurora, Leslie Davis, and Supriya Shore discuss individualized care strategies for patients with HF, with an emphasis on device-based therapies. The conversation kicks off with foundational HF treatments, briefly covers advanced options such as left ventricular assist device and heart transplant, and concludes with a review of established and emerging device therapies for patients who remain symptomatic but are not candidates for advanced interventions. This podcast is part of the ACC's Beyond the Pill: Advancing Heart Failure Care with Monitoring and Device Therapy initiative, supported by CVRx, Abbott, and Edwards Lifesciences. Subscribe to CardiaCast |